[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 5 - The Spring Supplement of Shefaye Khatam 2 - ::
Shefaye Khatam 2017, 5 - The Spring Supplement of Shefaye Khatam 2 -: 127-127 Back to browse issues page
P 96: Role of Thrombin in Inflammatory Central Nervous System (CNS) Diseases
Safieh Ebrahimi, Mohammad Jalili-Nik, Hossein Abde-Ahad, Mahdi Hassanian Seyed *
Department of Medical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , hasanianmehrm@mums.ac.ir
Abstract:   (1707 Views)

Thrombin is a multifunctional enzyme which has key roles in coagulation cascade and inflammatory events. The pro-inflammatory functions of thrombin occur by different mechanisms including increasing mast cell degranulation, up-regulating the expression of cell adhesion molecules (CAMs) and promoting the secretion of inflammatory chemokines and cytokines. Dysregulated signaling functions of thrombin contributes to the pathogenesis of pro-inflammatory diseases such as coronary thrombosis, pulmonary emboli, atherogenesis, and cancer and of special interest in this poster in central nervous system (CNS) associated inflammatory diseases. In support of the proinflammatory signaling function of thrombin in inflammatory CNS disease several reports demonstrated that PAR-1activation by thrombin elevates concentration of pro-inflammatory mediators like arachidonic acid, increases neutrophil chemoattractant-1, IL-1 and IL-8 in astrocytes. Similarly, PAR-1 has pro-inflammatory role in oligodendrocyte by inducing the expression of TNF-α and MMP-9. Furthermore, thrombin with activation of PAR-4 can induce pro-inflammatory signaling pathways including mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-kβ) in microglia cell line. PAR-4 also increases the expression and release of TNF-α from microglia leading to up-regulation of inducible nitric oxide synthase (iNOS) and as a consequence, incense in degeneration of dopaminergic neurons occurs. Consistently, thrombin plays a key role in the pathogenesis of neuro-degenerative diseases including stroke, multiple sclerosis Alzheimer and Parkinson. In support of these findings, it has been shown that administration of thrombin inhibitors including hirudin and a-NAPAP could decrease CNS inflammation related disease. Understanding the detail of pro-inflammatory signaling functions of thrombin and designing novel therapeutic agent to targeting this inflammatory serine protease can be a useful strategy for treatment of CNS inflammatory disorders, however the unfavorable pharmaceutical activities, toxicity, and risk of bleeding of these compounds needs to be further investigated.

Keywords: CNS thrombin system, Alzheimer’s disease, Parkinson’s disease, Thrombin, Inflammatory CNS disease
Full-Text [PDF 215 kb]   (463 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ebrahimi S, Jalili-Nik M, Abde-Ahad H, Hassanian M. P 96: Role of Thrombin in Inflammatory Central Nervous System (CNS) Diseases. Shefaye Khatam. 2017; 5 (S2) :127-127
URL: http://shefayekhatam.ir/article-1-1283-en.html


Volume 5 - The Spring Supplement of Shefaye Khatam 2 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 4212